Drug Delivery Technologies & Industry Analysis
In this section you will find information products, including market research reports, on the following sector: Drug Delivery
previous
| Transdermal Drug Delivery - Technologies, Markets, and Companies (JAI00041) This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various... | May 2012 | £1,895 |
| Cardiovascular Drug Delivery -Technologies, Markets and Companies (JAI00027) Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all... | May 2012 | £1,765 |
| Drug Delivery in Central Nervous System Diseases (JAI00031) Technologies, Markets and CompaniesThe delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,... | May 2012 | £1,895 |
| Drug Delivery in Cancer - technologies, markets and companies (JAI00030) Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug... | May 2012 | £2,525 |
| Oral Drug Delivery Market to 2017 (GBI00101) Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue GrowthOral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth Summary GBI Research, the leading business intelligence provider, has released its latest... | Apr 2012 | £2,210 |
| Advanced Oral & Parenteral Drug Delivery Technologies (ESP00745) Players, Products & Prospects to 2015 A comprehensive examination of trends and advances in the two major drug delivery sectors Unique sales forecasts to 2015 for key technology areas ... | Apr 2012 | £995 |
| Controlled-release: Players, products & prospects to 2018 (Volume I) (ESP00616) Controlled-release Delivery The controlled-release market was worth nearly US$21 billion globally in 2008. The sector is dominated by the launch of oral controlled-release formulations in key therapeutic areas such as... | Apr 2012 | £595 |
| Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV) (ESP00619) Targeted Delivery By 2018, over 30 new products will be launched resulting in a global market for advanced targeted delivery products worth over US$8.5 billion. Despite considerable advances in drug delivery technologies,... | Apr 2012 | £595 |
| World Biological Drugs Market (VIS00262) 2012-2022Your guide to biopharma industry trends and revenue prospects Where is the market for biological drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. Our new... | Feb 2012 | £1,699 |
| Drug Delivery: Surveying the Global Competitive Landscape (ESP00739) This report provides key insights for you to... Identify exciting development companies with novel drug delivery technologies Find out more about the competitive environment Profile the leading drug delivery companies... | Feb 2012 | £595 |
| Insulin Delivery Systems Market Forecast to 2014 (RCS00351) The global medical fraternity is alarmed at the rate at which the diabetic population has been increasing worldwide. It is expected that the number of diabetic patients in the world... | Feb 2012 | £885 |
| Drug Delivery Technologies: Commercial Prospects (VIS00236) 2012-2022How to find industry trends and revenue prospects there What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and... | Jan 2012 | £1,699 |
| Drug Delivery Systems (FED00151) US industry forecasts for 2015 & 2020US demand to rise 7.2% annually through 2015US demand for drug delivery products is forecast to expand 7.2 percent annually to $133 billion in 2015. The best growth opportunities will emerge in specialized pharmaceutical formulations... | Jan 2012 | £3,030 |
| Global Regenerative Medicine Market (RCS00818) Regenerative medicine is an emerging interdisciplinary field that spans tissue engineering, stem-cell biology, nanoscience, and bioengineering for the repair of cells, tissues and organs. It seeks to treat injured and... | Dec 2011 | £755 |
| Strategic Analysis of the Collagen Peptide Market in the United States (FRS02625) This study covers the U.S. market for collagen peptides. The historical period is from 2007, the forecast until 2017, and the base year is 2010. Market Engineering measurements, competitive analysis,... | Dec 2011 | £3,785 |
| Paget's Disease of Bone (PDB) Therapeutics (GDA03236) Pipeline Assessment and Market Forecasts to 2018Summary GlobalData, the industry analysis specialist, has released its new report, 'Paget's Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018'. The report is an essential source... | Dec 2011 | £2,210 |
| Global Drug Eluting DES, Bare Metal BMS and Other Coronary Stents Market (TAN00012) 2011 - 2016The coronary stents market has witnessed patterns of increasing market growth along with some declining phases in its course of span. The introduction of drug-eluting stents (DES) in year 2000... | Nov 2011 | £2,775 |
| Drug Delivery Device Market to 2017 (GBI00270) Metered Dose Inhalers and Infusion Pumps to Be Key Revenue GeneratorsDrug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators Summary GBI Research's report, "Drug Delivery Device Market to 2017 - Metered Dose Inhalers... | Sep 2011 | £2,210 |
| Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships (ESP00765) Assessing the Lipid-based, Polymer-based and Biovector delivery sectors An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses... | Sep 2011 | £1,295 |
| Market for Drug Delivery Systems in the US (TYR00072) The demand for drug delivery systems in the US is visualized to grow and reach over $135 billion by come 2015, as a result of growth of almost 9% every... | Sep 2011 | £220 |
| Medicaments (PLF00815) Analyse des performances des sociétés françaisesL'étude de portefeuille Plimsoll MEDICAMENTS - vous apporte une analyse détaillée et à jour des 264 sociétés opérant sur le marché. Cette étude est idéale pour toute personne qui cherche... | Aug 2011 | £495 |
| Medicine (Pharmaceutical Drug): Analysis of French Companies (PLF01330) The Plimsoll Analysis MEDICINE (Pharmaceutical drug) provides you with the most up to date and comprehensive analysis of the top 264 companies operating the market. It is ideal for... | Aug 2011 | £495 |
| Commerce De Detail De Produits Pharmaceutiques (PLF00435) Analyse des performances des sociétés françaisesL'étude de portefeuille Plimsoll COMMERCE DE DETAIL DE PRODUITS PHARMACEUTIQUES - vous apporte une analyse détaillée et à jour des 750 sociétés opérant sur le marché. Cette étude est idéale... | Aug 2011 | £495 |
| Retail Chemists : Analysis of French Companies (PLF01607) The Plimsoll Analysis RETAIL CHEMISTS provides you with the most up to date and comprehensive analysis of the top 750 companies operating the market. It is ideal for anyone... | Aug 2011 | £495 |
| Macular Degeneration (AMD) and Diabetic Retinopathy (DR) (VIS00308) World Drug Market 2011-2021What are the commercial prospects for the treatment of macular degeneration (AMD) and diabetic retinopathy (DR)? Our new report shows you potential revenues to 2021, discussing commercial opportunities and prospects.Our... | Jul 2011 | £1,499 |
